Coffee consumption has been associated with several benefits toward human health. However, its association with mortality risk has yielded contrasting results, including a non-linear relation to all-cause and cardiovascular disease (CVD) mortality and no association with cancer mortality. As smoking habits may affect the association between coffee and health outcomes, the aim of the present study was to update the latest dose-response meta-analysis of prospective cohort studies on the association between coffee consumption and mortality risk and conduct stratified analyses by smoking status and other potential confounders. A systematic search was conducted in electronic databases to identify relevant studies, risk estimates were retrieved from the studies, and dose-response analysis was modeled by using restricted cubic splines. A total of 31 studies comprising 1610,543 individuals and 183,991 cases of all-cause, 34,574 of CVD, and 40,991 of cancer deaths were selected. Analysis showed decreased all-cause [relative risk (RR) = 0.86, 95 % confidence interval (CI) = 0.82, 0.89)] and CVD mortality risk (RR = 0.85, 95 % CI = 0.77, 0.93) for consumption of up to 4 cups/day of coffee, while higher intakes were associated with no further lower risk. When analyses were restricted only to non-smokers, a linear decreased risk of all-cause (RR = 0.94, 95 % CI = 0.93, 0.96), CVD (RR = 0.94, 95 % CI = 0.91, 0.97), and cancer mortality (RR = 0.98, 95 % CI = 0.96, 1.00) for 1 cup/day increase was found. The search for other potential confounders, including dose-response analyses in subgroups by gender, geographical area, year of publication, and type of coffee, showed no relevant differences between strata. In conclusion, coffee consumption is associated with decreased risk of mortality from all-cause, CVD, and cancer; however, smoking modifies the observed risk when studying the role of coffee on human health.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Ranheim T, Halvorsen B. Coffee consumption and human health–beneficial or detrimental?–Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res. 2005;49(3):274–84. doi:10.1002/mnfr.200400109.
Loomis D, Guyton KZ, Grosse Y, et al. Carcinogenicity of drinking coffee, mate, and very hot beverages. Lancet Oncol. 2016;17(7):877–8. doi:10.1016/S1470-2045(16)30239-X.
Godos J, Pluchinotta FR, Marventano S, et al. Coffee components and cardiovascular risk: beneficial and detrimental effects. Int J Food Sci Nutr. 2014;65(8):925–36. doi:10.3109/09637486.2014.940287.
Aleksandrova K, Bamia C, Drogan D, et al. The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr. 2015;102(6):1498–508. doi:10.3945/ajcn.115.116095.
Jacobs S, Kroger J, Floegel A, et al. Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study. Am J Clin Nutr. 2014;100(3):891–900. doi:10.3945/ajcn.113.080317.
Koloverou E, Panagiotakos DB, Pitsavos C, et al. The evaluation of inflammatory and oxidative stress biomarkers on coffee-diabetes association: results from the 10-year follow-up of the ATTICA Study (2002–2012). Eur J Clin Nutr. 2015;69(11):1220–5. doi:10.1038/ejcn.2015.98.
Loftfield E, Shiels MS, Graubard BI, et al. Associations of coffee drinking with systemic immune and inflammatory markers. Cancer Epidemiol Biomark Prev. 2015;24(7):1052–60. doi:10.1158/1055-9965.EPI-15-0038-T.
Pellegrini N, Serafini M, Colombi B, et al. Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vitro assays. J Nutr. 2003;133(9):2812–9.
Jiang X, Zhang D, Jiang W. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr. 2014;53(1):25–38. doi:10.1007/s00394-013-0603-x.
Liu YJ, Zhan J, Liu XL, Wang Y, Ji J, He QQ. Dietary flavonoids intake and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Clin Nutr. 2014;33(1):59–63. doi:10.1016/j.clnu.2013.03.011.
Woo HD, Kim J. Dietary flavonoid intake and smoking-related cancer risk: a meta-analysis. PLoS ONE. 2013;8(9):e75604. doi:10.1371/journal.pone.0075604.
Malerba S, Turati F, Galeone C, et al. A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol. 2013;28(7):527–39. doi:10.1007/s10654-013-9834-7.
Je Y, Giovannucci E. Coffee consumption and total mortality: a meta-analysis of twenty prospective cohort studies. Br J Nutr. 2014;111(7):1162–73. doi:10.1017/S0007114513003814.
Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N. Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol. 2014;180(8):763–75. doi:10.1093/aje/kwu194.
Zhao Y, Wu K, Zheng J, Zuo R, Li D. Association of coffee drinking with all-cause mortality: a systematic review and meta-analysis. Public Health Nutr. 2015;18(7):1282–91. doi:10.1017/S1368980014001438.
Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 2014;129(6):643–59. doi:10.1161/CIRCULATIONAHA.113.005925.
Xie Y, Qin J, Nan G, Huang S, Wang Z, Su Y. Coffee consumption and the risk of lung cancer: an updated meta-analysis of epidemiological studies. Eur J Clin Nutr. 2015;. doi:10.1038/ejcn.2015.96.
Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301–9.
Orsini NBR, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 2006;6:40–57.
Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012;175(1):66–73. doi:10.1093/aje/kwr265.
Kahn HA, Phillips RL, Snowdon DA, Choi W. Association between reported diet and all-cause mortality. Twenty-one-year follow-up on 27,530 adult Seventh-Day Adventists. Am J Epidemiol. 1984;119(5):775–87.
Jacobsen BK, Bjelke E, Kvale G, Heuch I. Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst. 1986;76(5):823–31.
Vandenbroucke JP, Kok FJ, van ‘t Bosch G, van den Dungen PJ, van der Heide-Wessel C, van der Heide RM. Coffee drinking and mortality in a 25-year follow up. Am J Epidemiol. 1986;123(2):359–61.
LeGrady D, Dyer AR, Shekelle RB, et al. Coffee consumption and mortality in the Chicago Western Electric Company Study. Am J Epidemiol. 1987;126(5):803–12.
Rosengren A, Wilhelmsen L. Coffee, coronary heart disease and mortality in middle-aged Swedish men: findings from the Primary Prevention Study. J Intern Med. 1991;230(1):67–71.
Lindsted KD, Kuzma JW, Anderson JL. Coffee consumption and cause-specific mortality. Association with age at death and compression of mortality. J Clin Epidemiol. 1992;45(7):733–42.
Klatsky AL, Armstrong MA, Friedman GD. Coffee, tea, and mortality. Ann Epidemiol. 1993;3(4):375–81.
Hart C, Smith GD. Coffee consumption and coronary heart disease mortality in Scottish men: a 21 year follow up study. J Epidemiol Community Health. 1997;51(4):461–2.
Woodward M, Tunstall-Pedoe H. Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health. 1999;53(8):481–7.
Kleemola P, Jousilahti P, Pietinen P, Vartiainen E, Tuomilehto J. Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med. 2000;160(22):3393–400.
Iwai N, Ohshiro H, Kurozawa Y, et al. Relationship between coffee and green tea consumption and all-cause mortality in a cohort of a rural Japanese population. J Epidemiol. 2002;12(3):191–8.
Jazbec A, Simic D, Corovic N, Durakovic Z, Pavlovic M. Impact of coffee and other selected factors on general mortality and mortality due to cardiovascular disease in Croatia. J Health Popul Nutr. 2003;21(4):332–40.
Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women’s Health Study. Am J Clin Nutr. 2006;83(5):1039–46.
Paganini-Hill A, Kawas CH, Corrada MM. Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study. Prev Med. 2007;44(4):305–10. doi:10.1016/j.ypmed.2006.12.011.
Happonen P, Laara E, Hiltunen L, Luukinen H. Coffee consumption and mortality in a 14-year follow-up of an elderly northern Finnish population. Br J Nutr. 2008;99(6):1354–61. doi:10.1017/S0007114507871650.
Laaksonen M, Talala K, Martelin T, et al. Health behaviours as explanations for educational level differences in cardiovascular and all-cause mortality: a follow-up of 60 000 men and women over 23 years. Eur J Pub Health. 2008;18(1):38–43. doi:10.1093/eurpub/ckm051.
Ahmed HN, Levitan EB, Wolk A, Mittleman MA. Coffee consumption and risk of heart failure in men: an analysis from the Cohort of Swedish Men. Am Heart J. 2009;158(4):667–72. doi:10.1016/j.ahj.2009.07.006.
de Koning Gans JM, Uiterwaal CS, van der Schouw YT, et al. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol. 2010;30(8):1665–71. doi:10.1161/ATVBAHA.109.201939.
Leurs LJ, Schouten LJ, Goldbohm RA, van den Brandt PA. Total fluid and specific beverage intake and mortality due to IHD and stroke in the Netherlands Cohort Study. Br J Nutr. 2010;104(8):1212–21. doi:10.1017/S0007114510001923.
Sugiyama K, Kuriyama S, Akhter M, et al. Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J Nutr. 2010;140(5):1007–13. doi:10.3945/jn.109.109314.
Mineharu Y, Koizumi A, Wada Y, et al. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health. 2011;65(3):230–40. doi:10.1136/jech.2009.097311.
Tamakoshi A, Lin Y, Kawado M, et al. Effect of coffee consumption on all-cause and total cancer mortality: findings from the JACC study. Eur J Epidemiol. 2011;26(4):285–93. doi:10.1007/s10654-011-9548-7.
Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. New Engl J Med. 2012;366(20):1891–904. doi:10.1056/NEJMoa1112010.
Gardener H, Rundek T, Wright CB, Elkind MS, Sacco RL. Coffee and tea consumption are inversely associated with mortality in a multiethnic urban population. J Nutr. 2013;143(8):1299–308. doi:10.3945/jn.112.173807.
Liu J, Sui X, Lavie CJ, et al. Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin Proc. 2013;88(10):1066–74. doi:10.1016/j.mayocp.2013.06.020.
Ding M, Satija A, Bhupathiraju SN, et al. Association of Coffee consumption with total and cause-specific mortality in 3 large prospective cohorts. Circulation. 2015;132(24):2305–15. doi:10.1161/CIRCULATIONAHA.115.017341.
Lof M, Sandin S, Yin L, Adami HO, Weiderpass E. Prospective study of coffee consumption and all-cause, cancer, and cardiovascular mortality in Swedish women. Eur J Epidemiol. 2015;. doi:10.1007/s10654-015-0052-3.
Loftfield E, Freedman ND, Graubard BI, et al. Association of coffee consumption with overall and cause-specific mortality in a large US prospective cohort study. Am J Epidemiol. 2015;182(12):1010–22. doi:10.1093/aje/kwv146.
Odegaard AO, Koh WP, Yuan JM, Pereira MA. Beverage habits and mortality in Chinese adults. J Nutr. 2015;145(3):595–604. doi:10.3945/jn.114.200253.
Saito E, Inoue M, Sawada N, et al. Association of coffee intake with total and cause-specific mortality in a Japanese population: the Japan Public Health Center-based Prospective Study. Am J Clin Nutr. 2015;101(5):1029–37. doi:10.3945/ajcn.114.104273.
Grosso G, Stepaniak U, Micek A, Stefler D, Bobak M, Pajak A. Coffee consumption and mortality in three Eastern European countries: results from the HAPIEE (Health, Alcohol and Psychosocial factors In Eastern Europe) study. Public Health Nutr. 2016:1–10. doi:10.1017/S1368980016001749.
Greenberg JA, Dunbar CC, Schnoll R, Kokolis R, Kokolis S, Kassotis J. Caffeinated beverage intake and the risk of heart disease mortality in the elderly: a prospective analysis. Am J Clin Nutr. 2007;85(2):392–8.
Rosner SA, Akesson A, Stampfer MJ, Wolk A. Coffee consumption and risk of myocardial infarction among older Swedish women. Am J Epidemiol. 2007;165(3):288–93. doi:10.1093/aje/kwk013.
Cheng M, Hu Z, Lu X, Huang J, Gu D. Caffeine intake and atrial fibrillation incidence: dose response meta-analysis of prospective cohort studies. Canadian J Cardiol. 2014;30(4):448–54. doi:10.1016/j.cjca.2013.12.026.
Mostofsky E, Rice MS, Levitan EB, Mittleman MA. Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis. Circulation Heart Failure. 2012;5(4):401–5. doi:10.1161/CIRCHEARTFAILURE.112.967299.
Guertin KA, Loftfield E, Boca SM, et al. Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer. Am J Clin Nutr. 2015;101(5):1000–11. doi:10.3945/ajcn.114.096099.
Pham NM, Nanri A, Yasuda K, et al. Habitual consumption of coffee and green tea in relation to serum adipokines: a cross-sectional study. Eur J Nutr. 2015;54(2):205–14. doi:10.1007/s00394-014-0701-4.
Zimmermann-Viehoff F, Thayer J, Koenig J, Herrmann C, Weber CS, Deter HC. Short-term effects of espresso coffee on heart rate variability and blood pressure in habitual and non-habitual coffee consumers - A randomized crossover study. Nutr Neurosci. 2015;. doi:10.1179/1476830515Y.0000000018.
Grosso G, Marventano S, Galvano F, Pajak A, Mistretta A. Factors associated with metabolic syndrome in a mediterranean population: role of caffeinated beverages. J Epidemiol. 2014;24(4):327–33.
Liu H, Hu GH, Wang XC, et al. Coffee consumption and prostate cancer risk: a meta-analysis of cohort studies. Nutr Cancer. 2015;67(3):392–400. doi:10.1080/01635581.2015.1004727.
Sang LX, Chang B, Li XH, Jiang M. Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis. BMC Gastroenterol. 2013;13:34. doi:10.1186/1471-230X-13-34.
Tian C, Wang W, Hong Z, Zhang X. Coffee consumption and risk of colorectal cancer: a dose-response analysis of observational studies. Cancer Causes Control. 2013;24(6):1265–8. doi:10.1007/s10552-013-0200-6.
Li YM, Peng J, Li LZ. Coffee consumption associated with reduced risk of oral cancer: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121(4):381–9. doi:10.1016/j.oooo.2015.12.006.
Grosso G, Stepaniak U, Topor-Madry R, Szafraniec K, Pajak A. Estimated dietary intake and major food sources of polyphenols in the Polish arm of the HAPIEE study. Nutrition. 2014;30(11–12):1398–403. doi:10.1016/j.nut.2014.04.012.
Perez-Jimenez J, Fezeu L, Touvier M, et al. Dietary intake of 337 polyphenols in French adults. Am J Clin Nutr. 2011;93(6):1220–8. doi:10.3945/ajcn.110.007096.
Tresserra-Rimbau A, Medina-Remon A, Perez-Jimenez J, et al. Dietary intake and major food sources of polyphenols in a Spanish population at high cardiovascular risk: the PREDIMED study. Nutrition Metab Cardiovasc Dis NMCD. 2013;23(10):953–9. doi:10.1016/j.numecd.2012.10.008.
Zamora-Ros R, Knaze V, Rothwell JA, et al. Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Nutr. 2015;. doi:10.1007/s00394-015-0950-x.
Zujko ME, Witkowska AM, Waskiewicz A, Sygnowska E. Estimation of dietary intake and patterns of polyphenol consumption in Polish adult population. Adv Med Sci. 2012;57(2):375–84. doi:10.2478/v10039-012-0026-6.
Grosso GSU, Micek A, Pikhart H, Bobak B, Pajak A. Dietary polyphenols are inversely associated with metabolic syndrome in Polish adults of the HAPIEE study. Eur J Nutr. 2016. (ahead of print).
Lopez-Garcia E, van Dam RM, Qi L, Hu FB. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr. 2006;84(4):888–93.
Onakpoya IJ, Spencer EA, Thompson MJ, Heneghan CJ. The effect of chlorogenic acid on blood pressure: a systematic review and meta-analysis of randomized clinical trials. J Hum Hypertens. 2015;29(2):77–81. doi:10.1038/jhh.2014.46.
Jin UH, Lee JY, Kang SK, et al. A phenolic compound, 5-caffeoylquinic acid (chlorogenic acid), is a new type and strong matrix metalloproteinase-9 inhibitor: isolation and identification from methanol extract of Euonymus alatus. Life Sci. 2005;77(22):2760–9. doi:10.1016/j.lfs.2005.02.028.
Cardenas C, Quesada AR, Medina MA. Anti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene. PLoS ONE. 2011;6(8):e23407. doi:10.1371/journal.pone.0023407.
Wang S, Yoon YC, Sung MJ, Hur HJ, Park JH. Antiangiogenic properties of cafestol, a coffee diterpene, in human umbilical vein endothelial cells. Biochem Biophys Res Commun. 2012;421(3):567–71. doi:10.1016/j.bbrc.2012.04.046.
Cornelis MC, et al. Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Mol Psychiatry. 2015;20(5):647–56. doi:10.1038/mp.2014.107.
Author contribution: GG designed the study, performed the study search and wrote the manuscript; AM performed the analyses; JG built the databases and the tables; AP and MAMG provided insights on methodology and content; ELG and FG provided expertise on the topic and drafted the paper (equal contribution). All authors critically revised the paper.
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Figure 1. Dose-response association between coffee consumption and all-cause, CVD, and cancer mortality stratified by gender. Solid lines represent relative risk, dashed lines represent 95% confidence intervals. Supplementary material 1 (TIFF 168 kb)
Supplementary Figure 2. Dose-response association between coffee consumption and all-cause, CVD, and cancer mortality stratified by geographical area. Solid lines represent relative risk, dashed lines represent 95% confidence intervals. Supplementary material 2 (TIFF 247 kb)
Supplementary Figure 3. Dose-response association between coffee consumption and all-cause, CVD, and cancer mortality stratified by year of publication. Solid lines represent relative risk, dashed lines represent 95% confidence intervals. Supplementary material 3 (TIFF 168 kb)
Supplementary Figure 4. Dose-response association between coffee consumption and all-cause, CVD, and cancer mortality stratified by type of coffee. Solid lines represent relative risk, dashed lines represent 95% confidence intervals. Supplementary material 4 (TIFF 166 kb)
About this article
Cite this article
Grosso, G., Micek, A., Godos, J. et al. Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis. Eur J Epidemiol 31, 1191–1205 (2016). https://doi.org/10.1007/s10654-016-0202-2
- Cardiovascular disease
- Prospective cohorts